Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society.

Erickson, Claire M; Clark, Lindsay R; Ketchum, Fred B; Chin, Nathaniel A; Gleason, Carey E; Largent, Emily A.

Afiliación

Erickson CM; Neuroscience & Public Policy Program University of Wisconsin-Madison School of Medicine and Public Health Madison Wisconsin USA.
Clark LR; Wisconsin Alzheimer's Disease Research Center Department of Medicine Division of Geriatrics & Gerontology University of Wisconsin-Madison School of Medicine & Public Health Madison Wisconsin USA.
Ketchum FB; Wisconsin Alzheimer's Disease Research Center Department of Medicine Division of Geriatrics & Gerontology University of Wisconsin-Madison School of Medicine & Public Health Madison Wisconsin USA.
Chin NA; Geriatric Research Education & Clinical Center William S. Middleton Memorial Veterans Hospital Madison Wisconsin USA.
Gleason CE; Department of Neurology University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA.
Largent EA; Wisconsin Alzheimer's Disease Research Center Department of Medicine Division of Geriatrics & Gerontology University of Wisconsin-Madison School of Medicine & Public Health Madison Wisconsin USA.

Alzheimers Dement (Amst) ; 14(1): e12339, 2022.

Article en En | MEDLINE | ID: mdl-36035626